Management of high-degree atrioventricular block in the setting of cardiac sarcoidosis: A therapeutic controversy
Keywords:
cardiac sarcoidosis, atrioventricular block, managementReferences
-Obi ON, Lower EE, Baughman RP. Controversies in the Treatment of Cardiac Sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2022;39(2):e2022015.
-Yalta K, Yetkin E. Cardiac sarcoidosis: Indications for cardioverter-defibrillator therapy. CJC Open https://doi.org/10.1016/j.cjco.2022.07.003
- Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm 2014; 11(7): 1305-23.
-Yalta K, Yetkın E. Atrioventricular block in the setting of cardiac sarcoidosis: further implications. Heart Vessels 2022 Jul 5. doi: 10.1007/s00380-022-02136-6. Epub ahead of print. PMID: 35789419.
-Yodogawa K, Fujimoto Y, Hagiwara K, et al. Possibility of steroid therapy without pacemaker implantation in patients with sarcoidosis presenting atrioventricular block. Heart Vessels 2022 May 14. doi: 10.1007/s00380-022-02092-1. Epub ahead of print. PMID: 35568741.
-Yodogawa K, Seino Y, Shiomura R, et al. Recovery of atrioventricular block following steroid therapy in patients with cardiac sarcoidosis. J Cardiol 2013; 62(5): 320-5.
- Ishida M, Niwano S, Fujiyoshi K, et al. A case with recovery from high degree atrioventricular-block with steroid therapy in cardiac sarcoidosis with AH block: a possible new sign of responder? J Cardiol Cases 2020; 23(2): 90-93.
-Watanabe H, Eguchi K, Saitou T, et al. Cardiac sarcoidosis, the complete atrioventricular block of which was completely recovered by intravenous steroid pulse therapy. J Cardiol Cases 2015; 13(1): 21-4.
-Sugishita K, Togashi Y, Aizawa A, et al. Postpartum complete atrioventricular block due to cardiac sarcoidosis: steroid therapy without permanent pacemaker. Int Heart J 2008; 49(3): 377-84.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Kenan Yalta, Muhammet Gurdogan
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
